Angiodynamics Earnings Preview: Can This Streak Continue?

Angiodynamics (NASDAQ:ANGO) will report earnings after markets close on Monday, April 8th. AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company’s products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic’s product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.

Here is your Cheat Sheet to Angiodynamics Earnings:

Earnings Expectations: Analysts expect earnings of $0.05 per share on revenues of $81.70 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.12 to a profit $0.08. For the current year, the average estimate is a profit of $0.33, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Angiodynamics has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 166.50 195.05 216.04 215.75 221.79
Diluted EPS ($) 0.45 0.41 0.50 0.32 -0.20

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Nov. 30, 2011 Feb. 29, 2012 May. 31, 2012 Aug. 31, 2012 Nov. 30, 2012
Revenue ($) in millions 58.10 51.57 57.69 83.41 87.01
Diluted EPS ($) 0.09 -0.07 -0.27 -0.02 0.06

Past Performance:
Angiodynamics has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]